Patara Mastozytose Studie
Laufzeit: 01.01.2015 - 31.12.2016
Kurzfassung
Randomized, Double-Blind, Placebo-Controlled, Crossover Design, Efficacy and Safety Study with PA101 in Patients with Indolent Systemic Mastocytosis
Disodium Chromoglycate Inhalant
